Clinical Trial Update: Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia [NA]

View source ↗

Summary

A completed clinical trial evaluating ultraprotective ventilation without extracorporeal circulation in COVID-19–related acute respiratory distress syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Acute Respiratory Distress Syndrome, COVID19 | NA | Status: COMPLETED